<DOC>
	<DOCNO>NCT01098500</DOCNO>
	<brief_summary>A retrospective cohort study use LabRx medical claim database perform address objective . The primary objective project examine background rate liver function test ( LFT ) abnormalities cancer patient treat tyrosine kinase inhibitor ( TKIs ) .</brief_summary>
	<brief_title>Liver Function Test ( LFT ) Elevations Cancer Patients Users Tyrosine Kinase Inhibitor ( TKI ) Drugs</brief_title>
	<detailed_description>Patients recruit enrolled study . This study retrospective observational study . Data medical record insurance claim database anonymised use develop patient cohort . All diagnosis treatment record course routine medical practice .</detailed_description>
	<criteria>Adult ( age â‰¥18 year ) least two ICD9 code particular cancer ( ICD9 code 140208.9 ) within 6 month timeframe least one code TKI drug occur first cancer diagnosis code At least one month ( 30 day ) enrolment prior index date three month ( 91 day ) followup post index date ; Continuous enrolment LabRx database followup . Less 18 year old Less one month ( 30 day ) enrolment prior index date three month ( 91 day ) followup post index date ; Not continuously enrol LabRx database followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Liver function</keyword>
	<keyword>Tyrosine Kinase Inhibitor</keyword>
</DOC>